Skip to main content
. 2014 Aug 15;7(8):1967–1978.

Table 1.

Characteristics of studies included in the meta-analysis

Author, Year Cases Age1 EGFR Gender Smoking Histology TNM stage Detection

M1 W M2 F Y N ADC NADC I II/III/IV Sample Method
Qin B, 2005 [23] 41 NA 10 31 30 11 21 20 17 24 NA NA FFPE SE
Xu J, 2011 [24] 861 58 353 508 493 368 411 439 667 194 NA NA FFPE SE
An S, 2012 [25] 524 59.3 147 377 361 163 232 292 354 170 143 381 SFILN SE
Li Y, 2013 [26] 208 NA 51 157 147 61 130 78 95 113 49 159 FFPE SE
Jing C, 2013 [27] 120 62 48 72 69 51 NA NA 70 50 NA NA FFPE HRM
Liu Y, 2013 [16] 251 NA 140 111 138 113 NA NA 193 58 NA NA FFPE SE
Zhang Y, 2013 [28] 99 NA 33 66 68 31 43 56 54 45 16 83 FFPE ARMS
Lai Y, 2013 [14] 697 55.3 235 462 476 221 366 331 293 404 215 482 Fresh tissues ARMS
Zhang J, 2008 [29] 82 61 42 40 48 34 40 42 59 23 44 38 FFPE ARMS
Liang Z, 2008 [30] 290 58 121 169 145 145 NA NA 244 46 NA NA FFPE ARMS
Yin X, 2010 [31] 107 61 30 77 82 25 60 47 52 55 44 63 FFPE SE
Feng Q, 2011 [32] 309 59.7 105 204 184 125 132 127 201 99 NA NA FFPE SE
Sun M, 2011 [33] 443 57 189 254 243 200 NA NA 346 97 NA NA FFPE SE
Zhang J, 2011 [34] 454 59 219 235 256 198 279 175 340 114 NA NA FFPE SE
Wang L, 2011 [35] 184 58.5 69 115 106 78 79 105 135 49 NA NA FFPE BPSP
Gao J, 2012 [36] 120 65 44 76 77 43 60 60 93 27 NA NA FFPE ARMS
Sun L, 2013 [37] 301 59 99 202 174 127 173 128 188 113 NA NA FFPE SE
Zhang X, 2005 [38] 76 62.5 31 45 41 35 NA NA 51 25 NA NA FFPE SE
Wu Y, 2005 [15] 142 60 42 100 98 44 84 58 90 52 60 82 FFPE SE
Zhang L, 2005 [39] 52 58 10 42 39 13 33 19 28 24 NA NA FFPE SE
Zhou C, 2005 [40] 81 62 21 60 52 29 41 40 38 43 34 47 FFPE SE
Total 5442 2039 3403 3327 2115 2184 2017 3608 1825 605 1335

Abbreviations: Age1: median age; M1: mutant type EGFR; W: wild type EGFR; M2: male; F: female; Y: smoker; N: non-smoker; ADC: adenocarcinoma; NADC: non-adenocarcinoma NSCLC; NA: not available; FFPE: formalin-fixed, paraffin-embedded tissues; SFILN: snap-frozen tissues in liquid nitrogen; SE: sequencing; HRM: high resolution melting analysis; ARMS: amplification mutation refractory system; BPSP: bi-loop probe and specific primer quantitative PCR.